Noevir Holdings Co Ltd
TSE:4928

Watchlist Manager
Noevir Holdings Co Ltd Logo
Noevir Holdings Co Ltd
TSE:4928
Watchlist
Price: 4 760 JPY -1.55%
Market Cap: 162.6B JPY
Have any thoughts about
Noevir Holdings Co Ltd?
Write Note

Noevir Holdings Co Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Noevir Holdings Co Ltd
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Noevir Holdings Co Ltd
TSE:4928
Cash Equivalents
ÂĄ29.2B
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
-4%
Shiseido Co Ltd
TSE:4911
Cash Equivalents
ÂĄ85B
CAGR 3-Years
-19%
CAGR 5-Years
-3%
CAGR 10-Years
-2%
Rohto Pharmaceutical Co Ltd
TSE:4527
Cash Equivalents
ÂĄ64.5B
CAGR 3-Years
-2%
CAGR 5-Years
11%
CAGR 10-Years
13%
Kao Corp
TSE:4452
Cash Equivalents
ÂĄ304.5B
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
14%
Kose Corp
TSE:4922
Cash Equivalents
ÂĄ116.7B
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
12%
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Cash Equivalents
ÂĄ41.2B
CAGR 3-Years
-21%
CAGR 5-Years
-9%
CAGR 10-Years
-2%
No Stocks Found

Noevir Holdings Co Ltd
Glance View

Market Cap
162.6B JPY
Industry
Consumer products

In the versatile world of beauty and wellness, Noevir Holdings Co Ltd. stands as a testament to astute innovation combined with a well-honed business acumen. Founded in Japan, this company has expertly navigated the delicate balance of tradition and modernity to emerge as a prominent figure in the skincare and cosmetic industries. Noevir's strategy is rooted in the meticulous formulation of its products, drawing inspiration from natural ingredients, which reflects the company’s keen attention to quality and detail. By leveraging advanced research and development techniques, Noevir crafts a diverse range of skincare and personal care products designed to cater to the discerning needs of its clientele. They operate primarily through direct sales channels, allowing them to maintain a personal relationship with their customers, understanding their preferences deeply and ensuring a consistent brand experience. Financially, Noevir Holdings generates revenue by employing a multi-faceted business model, anchoring itself in both domestic and international markets. Besides its leading role in the cosmetics sector, the company diversifies through its involvement in pharmaceuticals and health foods, broadening its portfolio to mitigate market risks. This diversity not only stabilizes the company’s revenue streams but also aligns with the increasing consumer emphasis on holistic health and wellness solutions. Noevir's ability to anticipate and respond to market trends ensures its growth trajectory, having firmly established its brand in the Asian market while progressively expanding its footprint across regions. As a result, the company's strategy encompasses not just product innovation but also a robust marketing and distribution network that reinforces its position as a leader in the beauty and wellness industry.

Intrinsic Value
5 050.03 JPY
Undervaluation 6%
Intrinsic Value
Price

See Also

What is Noevir Holdings Co Ltd's Cash Equivalents?
Cash Equivalents
29.2B JPY

Based on the financial report for Sep 30, 2024, Noevir Holdings Co Ltd's Cash Equivalents amounts to 29.2B JPY.

What is Noevir Holdings Co Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
-4%

Over the last year, the Cash Equivalents growth was 1%. The average annual Cash Equivalents growth rates for Noevir Holdings Co Ltd have been -2% over the past three years , -1% over the past five years , and -4% over the past ten years .

Back to Top